Trials / Completed
CompletedNCT04456465
Pain Diabetic Peripheral Neuropathy(DPN) in China
Clinical Characteristics and Treatment of Pain Diabetic Peripheral Neuropathy(DPN) in China: a Multi-center Cross-sectional Survey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To understand the clinical characteristics of DPN patients in China; To investigate the distribution of DPN patients with depression and anxiety symptoms; To investigate the related factors of moderate and severe pain in DPN patients; To investigate the treatment of pain and depression and/or anxiety in DPN patients.
Detailed description
Pain diabetic peripheral neuropathy (DPN) is a heavy global economic burden. An American observational study in 2013 showed that the total average annual adjusted direct medical cost/person for DPN patients was $4,841, and the total average annual adjusted indirect medical cost/person was $9,730. A retrospective study in the United States in 2015 showed that the total annual direct medical cost per person for diabetes was $6,632, DPN ($12,492), DPN ($27,931), and severe DPN ($30,755) were 4.6 times higher than those for patients with diabetes alone. According to the 2015 European survey, the total annual direct medical cost per person for DPN patients in the United Kingdom was €2,963 (£2,511), of which 40% was used for hospitalization. At present, there are no studies on the population epidemiology, depression and drug use of DPN in China. This study mainly investigates the above problems.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pain diabetic peripheral neuropathy | Neuropathic pain is the focus of current clinical research, clinical identification, and treatment. It is unique from nociceptive pain and requires evaluation of the relevance and utility of common pain measures created for other painful conditions. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2020-07-02
- Last updated
- 2020-07-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04456465. Inclusion in this directory is not an endorsement.